Home / Stock ratings / AI Data Center and Power Stocks / EMR
Stock rating · Electronic & Other Electrical Equipment (No Computer Equip)
Emerson Electric Co. (EMR) Stock Rating & Analysis
As of October 6, 2026, MELANY rates Emerson Electric Co. 62 out of 100 (Runner!). Its highest factor score is catalyst setup at 79, and its lowest is valuation at 45.
MELANY ratingRated 2026-10-06EMR · composite score
About Emerson Electric Co.
Emerson Electric, founded in 1890 as North America's first manufacturer of electric fans, has become a major industrial automation player through acquisitions of established brands. It organizes its business into seven segments selling automation software, power tools, and automation hardware such as valves, gauges, and switches. In recent years it divested its climate technology and consumer businesses to focus more on industrial automation.
Rating as of 2026-10-06 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why EMR scores 62/100
EMR's 8 factor scores run from 45 to 79, and 6 of them sit above its composite of 62. Here is how EMR breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 22.2x, earnings growth accelerating
Margins, returns on capital, and balance-sheet strength.
- Gross margin 53%
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Earnings in 29 days (strong beat history)
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
- Earnings in 29 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How EMR compares
As of October 7, 2026, Emerson Electric Co. is tied for 10th of 20 in AI Data Center and Power Stocks, where the average score is 62.
Also ranked in Robotics and Automation Stocks, Industrial Stocks. All stock rating pages.
Key risks for EMR
- Performance partly driven by AI data center buildout, rotation away from this theme would hurt
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Emerson Electric Co. sits in the AI data center buildout theme, which MELANY currently rates 95/100 for strength. Theme strength feeds EMR's momentum and catalyst factors above.
EMR trade plan (Pro)
MELANY has a full position plan for Emerson Electric Co.: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates EMR
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Emerson Electric Co.'s 62/100 reflects mature factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about EMR
Is Emerson Electric Co. (EMR) a buy?
As of 2026-10-06, MELANY rated Emerson Electric Co. Runner! with a composite score of 62/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Emerson Electric Co.'s MELANY score?
Emerson Electric Co. (EMR) has a MELANY composite score of 62/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the EMR stock rating calculated?
MELANY scores EMR from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Emerson Electric Co. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Emerson Electric Co. (EMR) Runner! with a composite of 62/100 as of 2026-10-06. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the EMR stock price forecast?
MELANY does not publish price targets or forecasts for EMR. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 62/100 across eight factors for Emerson Electric Co., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is EMR stock overvalued or undervalued?
MELANY's valuation factor currently reads 45/100 for Emerson Electric Co., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives EMR's read.
What price should I buy EMR at?
Rather than chasing the current price, MELANY computes a smart entry zone for EMR: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying EMR stock?
The top risks MELANY currently flags for Emerson Electric Co.: Performance partly driven by AI data center buildout, rotation away from this theme would hurt; Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Emerson Electric Co. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 66/100 for Emerson Electric Co., and earnings track record, at 64/100. The 62/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will EMR stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 68/100 for EMR right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this EMR rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-06. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores EMR continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, EMR included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.